AI in Oncology Market 2024 Highlights on Future Development, Top Trends and Leading Players Analysis to 2031 | Azra AI, Siemens Healthineers AG.

The report named, "Global AI in Oncology Market Research Report 2024" has been added to the archive of market research studies by DataM Intelligence. The industry experts and researchers have offered reliable and precise analysis of the global AI in Oncology market in view of numerous aspects such as growth factors, challenges, limitations, developments, trends, and growth opportunities. This report will surely act as a handy instrument for the market participants to develop effective strategies with an aim to reinforce their market positions. This report offers pin-point analysis of the changing dynamics and emerging trends in the global AI in Oncology market. Additionally, it provides a futuristic perspective on various factors that are likely to boost the global AI in Oncology market growth in the years to come. Besides, authors of the report have shed light on the factors that may hamper the growth of the global AI in Oncology market.

Get PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart): https://www.datamintelligence.com/download-sample/ai-in-oncology-market

The AI in Oncology Market refers to the segment of the healthcare and technology industries focused on the development, deployment, and utilization of artificial intelligence (AI) technologies to enhance cancer care. This market encompasses a wide range of AI applications and tools designed to improve various aspects of oncology, including diagnosis, treatment planning, patient management, drug discovery, and research. Key components and areas of the AI in Oncology Market

Market Growth:

The growth of the AI in Oncology Market is significantly driven by initiatives from both public and private organizations investing in research and development (R&D) for the introduction of novel technologies.

For example, in October 2022, Tempus, a company specializing in precision medicine and AI, launched Tempus+, a proprietary program that leverages real-world data to enhance collaborative precision oncology research. This program is already being utilized by a community of researchers from institutions such as Baylor College of Medicine, Allegheny Health Network, Stanford Cancer Center, Rush University Medical Center, and TriHealth to advance their research efforts.

Additionally, the increasing approval of AI-associated medical devices is expected to further propel market growth. In January 2024, the U.S. FDA approved DermaSensor, the first AI medical device for detecting skin cancer, marking a significant milestone in the adoption of AI technologies in oncology.

Who is the largest manufacturers of AI in Oncology Market worldwide?:

Azra AI, Siemens Healthineers AG, GE Healthcare, NVIDIA Corporation, Digital Diagnostics Inc, ConcertAI LLC, Median Technologies Inc, PathAI, Medtronic among others.

To Know More Insights - https://www.datamintelligence.com/research-report/ai-in-oncology-market

SEGMENT Analysis:

By Component Type : Services, Software Solutions, Hardware.

By Cancer Type : Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor.

By Application : Cancer Detection, Drug Discovery, Drug Development.

By End User : Hospitals, Surgical Centers, Pharmaceutical Companies.

Which regions are leading the AI in Oncology Market?
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Objectives of the Report

-To carefully analyze and forecast the size of the AI in Oncology market by value and volume.
-To estimate the market shares of major segments of the AI in Oncology market.
-To showcase the development of the AI in Oncology market in different parts of the world.
-To analyze and study micro-markets in terms of their contributions to the AI in Oncology market, their prospects, and individual growth trends.
-To offer precise and useful details about factors affecting the growth of the AI in Oncology market.
-To provide a meticulous assessment of crucial business strategies used by leading companies operating in the AI in Oncology market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.

Key questions answered

How feasible is AI in Oncology market for long-term investment?
What are influencing factors driving the demand for AI in Oncology near future?
What is the impact analysis of various factors in the Global AI in Oncology market growth?
What are the recent trends in the regional market and how successful they are?

Get Customization in the report as per your requierments: https://www.datamintelligence.com/customize/ai-in-oncology-market

Company Name: DataM Intelligence
Contact Person: Sai.K
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website:https://www.datamintelligence.com/

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.